REFERENCES
- Shoulson I., Glaubiger G.A., Chase T.N. Neurology 1975; 25: 1144–1148
- Quinn N.P. Drugs 1984; 28: 236–262
- Sudo J., Iwase H., Terui J. Eur. J. Pharm. Sci. 1998; 7: 67–71
- Iwase H., Sudo J., Terui J. Drug Dev. Ind. Pharm. 2000; 26: 755–759
- Murata M., Mizusawa H., Yamanouchi H., Kanazawa I. J. Neural. Transm. 1996; 103: 1177–1185
- Vaughan J.R., Joyce A.E. J. Am. Chem. Soc. 1953; 75: 5556–5560
- Ohara N., Takayama K., Machida Y., Nagai T. Int. J. Pharm. 1994; 105: 31–38
- Sudo J., Iwase H., Terui J., Hayashi T., Soyama M. Biol. Pharm. Bull. 1995; 18: 610–614
- Eriksson B.-M., Persson B.-A. J. Chromatogr. 1982; 228: 143–154
- Rahman M.K., Nagatsu T., Kato T. Biochem. Pharmacol. 1981; 30: 645–649
- Sperk G., Galhaup I., Schlögl E., Hörtnagl H., Hornykiewicz O. J. Neurochem. 1980; 35: 972–976
- Borchardt R.T., Vince W.C., Grunewald G.L. Anal. Biochem. 1977; 82: 149–157
- Ellenhorn M.J., Barceloux D.G. Medical Toxicology. Diagnosis and Treatment of Human Poisoning. Elsevier, Amsterdam 1988; 16–17
- Reimherr F.W., Wood D.R., Wender P.H. Am. J. Psychiatry 1980; 137: 73–75